autoimmune diseases

15th International Symposium on Sjögren's Syndrome

The 15th international symposium on Sjögren's Syndrome will take place in Rome from 7 to 10 September 2022.

New study to investigate ianalumab and its mechanism of efficacy in Sjögren's patients

New study to investigate the ianalumab monoclonal antibody and its mechanism of efficacy in Sjögren's patients

EULAR 2022

EULAR 2022 to take place from 1 to 4 June

Transfer Technology Prize: Olivier Mignen and his group awarded

Dr. Olivier Mignen and his team have been awarded the prize of 'Transfer of Technology' by Ouest Valorisation.

Machine learning identifies a common signature for anti-SSA/Ro60 antibody expression across autoimmune diseases

Autoantibodies are markers of autoimmune diseases. The most frequently observed is the anti-SSA/Ro autoantibody. It is observed in Gougerot-Sjögren syndrome, systemic lupus erythematosus, undifferentiated connectivites but also sometimes in rheumatoid arthritis and scleroderma. Using artificial intelligence approaches on multi-omics data [...]

Successful application to MSCA Doctoral Networks 2021 call

LBAI will be involved in a new European project after the successful application of the SIGNATURE proposal to the MSCA Doctoral Networks 2021 call.